Diligent rigorous, innovative dedicated
Cheng Yi Pharmaceutical was founded in 1966 and is now a comprehensive modern pharmaceutical enterprise specializing in the production of capsules, injections, tablets, raw materials, and pharmaceutical intermediates. On March 15, 2017, it landed on the main board of the Shanghai Stock Exchange (stock code: 603811) and is a national high-tech enterprise, one of the top 100 enterprises in the Chinese chemical and pharmaceutical industry, the first listed marine biopharmaceutical company in Zhejiang Province, a leading and comprehensive top 100 enterprise in Wenzhou City, and a meritorious enterprise in Dongtou District.
Yan Yiyi has also twice won the title of Outstanding Communist Party Member of Zhejiang Province, repeatedly won the title of model worker of Wenzhou City, and repeatedly been awarded the title of Meritorious Entrepreneur of Wenzhou City by the Municipal Party Committee and the Municipal Government.
In January 1980, Yan Yiyi was appointed as the director of Tongshan Pharmaceutical Factory by Dongtou County Committee. Over the past 40 years, along with the reform and opening up, he has run a good enterprise, brought a good team, assumed a responsibility, and condensed a spirit to make a small pharmaceutical factory of family members of island troops with almost no advantages in transportation, capital, cost and talents a listed company on the main board, which can be described as touching China! In recent years, he has vigorously promoted the regulation, listing and listing of enterprises, set an example in the construction of "two healths", set a benchmark in high-quality development, and played an important role in honest management and serving the society. He is an excellent model of Wenzhou's socialist construction.
Cheng Yi Pharmaceutical was founded in October, 1966. After four renaming and three relocations, it has developed from an unknown small pharmaceutical factory for family members of island troops 55 years ago to the first listed company of marine biomedicine in Zhejiang Province with a domestic first-class "smart pharmaceutical factory". Marine biomedicine such as glucosamine hydrochloride and super fish oil are the biggest brands of Cheng Yi Pharmaceutical In the future, Cheng Yi Pharmaceutical will focus on the three development directions of "marine medicine, biomedicine and traditional Chinese medicine" and the goal of "10 billion market value, a century-old enterprise", speed up mergers and acquisitions, seize the strategic commanding heights, empower enterprises with new values, realize the company's collectivization and high-quality development, and build the "aircraft carrier" of medicine in southern Zhejiang.
The company can produce more than 60 varieties and nearly 100 specifications of drugs, among which the marine biomedical "glucosamine hydrochloride" series for the treatment and prevention of systemic osteoarthritis and the nervous system drug "gastrodin" have the first market share in domestic similar products; The high-efficiency diuretic "torasemide" series was included in the national torch plan project; The antiviral drug "Ribavirin" won the national invention patent award and was included in the national COVID-19 diagnosis and treatment plan; Azathioprine, an anti-tumor drug, thiopurine, a drug for treating childhood leukemia, and Danyining tablets, a Chinese patent medicine for treating cholecystitis and biliary tract infection, are the company's characteristic varieties. All products have passed the national GMP certification, and took the lead in international certification in 1998. Many products have passed the certifications of the US FDA, EU EMEA, Australia TGA, UK MHRA, Mexico COFEPRIS and other countries and regions.